Physician profile
Johnathan Williams
NPI 1326304049
$8,916.66
in general payments reported to CMS, 2019-2025
22 companies · $576 in 2025
The $576 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,774 · 2020: $170 · 2021: $1,545 · 2022: $1,483 · 2023: $310 · 2024: $59.75 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $945.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,397.68 | 2019-2022 | |
| Pylant Medical | $1,985.29 | 2021-2025 | |
| Cgg Medical INC | $1,710.00 | 2019 | |
| Stryker Corporation | $937.06 | 2020-2025 | Mako, Blueprint Patient Specific Instrumentation, Aequalis Ascend Flex |
| Zimmer Biomet Holdings, INC. | $291.64 | 2021-2025 | Mymobility Platform, Gel-One Cross-Linked Hyaluronate |
| Vertex Pharmaceuticals Incorporated | $162.69 | 2025 | |
| Bioventus LLC | $86.70 | 2022-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Sanara Medtech INC. | $41.50 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $33.07 | 2023 | Seglentis |
| Pacira Pharmaceuticals Incorporated | $31.71 | 2021-2023 | Iovera, Zilretta |
| Trice Medical, INC. | $31.51 | 2023 | |
| Pacira Therapeutics, INC. | $30.23 | 2021 | |
| Anika Therapeutics, INC. | $25.37 | 2023 | Revomotion |
| Avanos Medical | $24.67 | 2025 | On-Q Pump and Accessories |
| Baxter Healthcare | $22.14 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $22.02 | 2019 | |
| Medline Industries Lp | $16.88 | 2019 | |
| Depuy Synthes Sales INC. | $16.69 | 2024 | Monovisc, Orthovisc |
| Paratek Pharmaceuticals, INC. | $15.14 | 2022 | |
| Allergan, INC. | $12.68 | 2019 | |
| Qiagen, LLC | $12.21 | 2019 | |
| Ossur Americas, INC. | $9.78 | 2024 | Miami J |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnathan Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.